Ten-year surveillance of invasive Streptococcus pneumoniae isolates in central Turkey prior to the introduction of a conjugate vaccine

Journal of Infection in Developing Countries

Volumn 4, Issue 9, 2010, Pages 560-565

  Percin, Duygu ^a   Altintop, Yasemin Ay ^a   Sumerkan, Bulent ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Antimicrobial susceptibility; Serotyping; Streptococcus pneumoniae; Vaccine

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; STREPTOCOCCUS VACCINE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; CEREBROSPINAL FLUID CULTURE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TURKEY (REPUBLIC);

STREPTOCOCCUS PNEUMONIAE;

EID: 78049484315     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.834     Document Type: Article

References (27)

1. Caputo GM, Appelbaum PC, Liu HH (1993) Infections due to penicillin-resistant pneumococci: clinical, epidemiologic and microbiologic features. Arc Intern Med 153: 1301-1310.
2. Esel D, Doganay M, Alp E, Sumerkan B (2003) Prospective evaluation of blood cultures in a Turkish university hospital: epidemiology, microbiology and patient outcome. Clin Microbiol Infect 9: 1038-1044.
3. Firat M, Ersoy Y, Esel D, Bayraktar M, Caylan R, Durmaz R (2006) Antimicrobial susceptibility and serotype distribution of pneumococci strains isolated from meningitis patients. Mikrobiyol Bult 40: 169-177.
4. Gur D, Guciz B, Hascelik G, Esel D, Sumerkan B, Over U, Soyletir G, Ongen B, Kaygusuz A, Toreci K (2001) Streptococcus pneumoniae penicillin resistance in Turkey. J Chemother 13: 541-545.
5. Esel D, Sumerkan B, Kocagoz S (2001) Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in Kayseri, Turkey. Clin Microbiol Infect 7: 548-552.
6. Yalcin I, Gurler N, Alhan E, Yaman A, Turgut M, Celik U, Akçakaya N, Camcioglu Y, Diren S, Yildirim B (2006) Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004. Eur J Pediatr 165: 654-657.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI document M100-S18. Clinical and Laboratory Standards Institute, 940 West Walley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2008.
8. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K (2000) Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis 19: 187-195.
9. Klein DL (2000) Pneumococcal disease and the role of conjugate vaccines. In Tomasz A (ed): Streptococcus pneumoniae: Molecular Biology and Mechanisms of Disease, 1st ed. Larchmont: Mary Ann Liebert Inc, 467-477.
10. Paraskakis I, Kafetzis DA, Chrisakis A, Papavasilliou H, Kirikou H, Pangalis A, Tzouvelekis LS, Athanasiou T, Legakis NJ; National Surveillance Network for Pneumococcal Resistance (2006) Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004. Clin Microbiol Infect 12: 478-495.
11. Ispahani P, Slack RCB, Donald FE, Weston VC, Rutter N (2004) Twenty year surveillance of invasive pneumococcal disease in Nottinham: serogroups responsible and implications for immunisation. Arch Dis Child 89: 757-762.
12. Adegbola RA, Hill PC, Secka O, Ikumapayi UN, Lahai G, Greenwood BM, Corrah T (2006) Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health 11: 1128-1135.
13. McChlery SM, Scott KJ, Clarke SC (2005) Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy. Eur J Clin Microbiol Infect Dis 24: 262-267.
14. Mokaddas EM, Rotimi VO, Albert MJ (2008) Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. Clin Vaccine Immunol 15: 203-207.
15. Shibl A, Memish Z, Pelton S (2009) Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt. Int J Antimicrob Agents 33: 410.e1-9.
16. Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T (2004) Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 4: 21. DOI: 10.1186/1471-2334-4-21.
17. Whitney CG, Philisvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A. (2006) Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368: 1495-1502.
18. Dias R, Canica M (2007) Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine. FEMS Immunol Med Microbiol 51: 35-42.
19. Shapiro ED, Clemens CD (1984) A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med 101: 325-330.
20. Del Vechio MT, Aronoff SC (2003) Invasive Streptococcus pneumoniae disease in a vaccinated child. Clin Microbiol News 25: 102-103.
21. Brandao AP, de Oliveira TC, de Cunto Brandileone MC, Goncalves JE, Yara TI, Simonsen V (2004) Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil. Vaccine 23:762-8.
22. Owerveg K, Sluijter M, Srodzinski M, de Groot R, Hermans PWM (2000) Immune-protective antibodies against capsular polysaccharides do not affect natural competence of Streptococcus pneumoniae: implications for current conjugate vaccination strategies. FEMS Immunol Med Microbiol 29: 183-185.
23. Moberley S, Holden J, Tatham DP, Andrews RM (2009) Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 3: 1-42.
24. Huss A, Scott P, Stuck AE, Trotter C, Egger M (2009) Efficacy of pneumococcal vaccination in adults: a meta-analysis. Can Med Assoc J 180: 48-58.
25. Pagliano P, Fusco U, Attanasio V, Rossi M, Conte M, Faella FS (2007) Pneumococcal meningitis in childhood: a longitutinal prospective study. FEMS Immunol Med Microbiol 51: 488-495.
26. Friedland IR, McCracken GH (1994) Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 331: 377-382.
27. Figuiredo AMS, Connor JD, Severin A, Vaz Pato MV, Tomasz A (1992) A pneumococcal clinical isolate with high level resistance to cefotaxime and ceftriaxone. Antimicrob Agent Chemother 36: 886-889.